(Q54766008)

3 June 2018

title

Tumor-associated antigen profiling in breast and ovarian cancer: mRNA, protein or T cell recognition? (English)

1 reference

3 June 2018

1 reference

Simone Kayser

1

1 reference

3 June 2018

Iris Watermann

2

1 reference

3 June 2018

Christine Rentzsch

3

1 reference

3 June 2018

Toni Weinschenk

4

1 reference

3 June 2018

Diethelm Wallwiener

5

1 reference

3 June 2018

Brigitte Gückel

6

1 reference

3 June 2018

publication date

26 June 2003

1 reference

3 June 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

3 June 2018

volume

129

1 reference

3 June 2018

issue

7

1 reference

3 June 2018

page(s)

397-409

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1007/s00432-003-0445-7

exact match

0 references

cites work

High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy.

1 reference

12 December 2020

Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity

1 reference

12 December 2020

MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution

1 reference

12 December 2020

Carcinoembryonic antigen in staging and follow-up of patients with solid tumors

1 reference

12 December 2020

Expression of MAGE-1, MAGE-2, MAGE-3/-6 and MAGE-4a/-4b genes in ovarian tumors

1 reference

12 December 2020

Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?

1 reference

12 December 2020

Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction

1 reference

12 December 2020

Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer

1 reference

12 December 2020

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens

1 reference

12 December 2020

HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions

1 reference

12 December 2020

In situ expression of transforming growth factor ?? is associated with melanoma progression and correlates with Ki67, HLA-DR and ?? 3 integrin expression

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer

1 reference

12 December 2020

A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas

1 reference

12 December 2020

Interactions between the immune system and breast cancer

1 reference

12 December 2020

Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells

1 reference

12 December 2020

LAGE-1, a new gene with tumor specificity

1 reference

12 December 2020

Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells

1 reference

12 December 2020

Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study.

1 reference

12 December 2020

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

1 reference

12 December 2020

Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes

1 reference

12 December 2020

Identification of tumour-associated T-cell epitopes for vaccine development

1 reference

12 December 2020

Sequence and expression pattern of the human MAGE2 gene

1 reference

12 December 2020

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours

1 reference

12 December 2020

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40

1 reference

12 December 2020

Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.

1 reference

12 December 2020

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

1 reference

12 December 2020

A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry.

1 reference

12 December 2020

Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid

1 reference

12 December 2020

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model

1 reference

12 December 2020

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

1 reference

12 December 2020

Natural history of HLA expression during tumour development.

1 reference

12 December 2020

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

12 December 2020

HLA and cancer: from research to clinical impact

1 reference

12 December 2020

Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy.

1 reference

12 December 2020

Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro

1 reference

12 December 2020

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies

1 reference

12 December 2020

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

1 reference

12 December 2020

Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens

1 reference

12 December 2020

Integrated functional genomics approach for the design of patient-individual antitumor vaccines.

1 reference

12 December 2020

Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue

1 reference

12 December 2020

CD80-transfected human breast and ovarian tumor cell lines: improved immunogenicity and induction of cytolytic CD8+ T lymphocytes.

1 reference

12 December 2020

Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines

1 reference

12 December 2020

Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors

1 reference

12 December 2020

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

1 reference

12 December 2020

Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo

1 reference

12 December 2020

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

12 December 2020

Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells

1 reference

12 December 2020

Reduced expression of MHC class I antigen in human cancer cell lines with defective LMP-7

1 reference

12 December 2020

The major substrates for TAP in vivo are derived from newly synthesized proteins

1 reference

12 December 2020

Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

1 reference

12 December 2020

Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis

1 reference

12 December 2020

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

12 December 2020

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

1 reference

12 December 2020

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 December 2020

The makings of a tumor rejection antigen

1 reference

12 December 2020

Antigen-processing machinery breakdown and tumor growth

1 reference

12 December 2020

10.1007/S00432-003-0445-7

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018